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An enzyme-linked immunosorbent assay (ELISA) was developed for detection of bovine serum antibodies to
the cytotoxin (leukotoxin) of Pasteurela haemolytica. A partially purified, cytotoxic, and immunogenic protein
obtained from supernatants of logarithmic-phase P. haemolytica was used as the ELISA antigen. Preadsorption
of sera with various cytotoxic, somatic, and capsular antigen preparations demonstrated that the assay was
specific for anticytotoxin antibodies. ELISA anticytotoxin titers had a strong, significant correlation to
cytotoxin-neutralizing-antibody titers. The ELISA, however, was more rapid and allowed for greater numbers
of samples to be run than did the neutralization technique. ELISA anticytotoxin titers were high in cattle
vaccinated with a live P. haemolytica vaccine, whereas unvaccinated cattle and cattle receiving a P. haemolytica
bacterin had low ELISA anticytotoxin titers. A significant positive correlation between ELISA titers and
resistance to experimental bovine pneumonic pasteurellosis was present.
Bovine pneumonia pasteurellosis is a severe fibrinous
pneumonia of feedlot cattle usually associated with infection
by Pasteurella haemolytica biotype A, serotype 1 (5, 16, 17).
Various approaches used to prevent the disease have proven
largely unsuccessful, and pneumonia pasteurellosis contin-
ues to be a major problem for the feedlot industry (16, 19).
Recent studies have concentrated on defining the role
played by humoral immunity in resistance to pneumonia
pasteurellosis. Clinical use of P. haemolytica bacterins has
not proven effective (1, 18, 20). Cattle given bacterins
developed an antibody response to somatic antigens, but this
response did not consistently result in protection against P.
haemolytica challenge (8, 14). Live P. haemolytica vaccines
given by aerosol or parenteral routes, however, resulted in
both increased antibody titers to somatic antigens and en-
hanced resistance to experimental challenge (22). Similarly,
enhanced resistance to challenge was noted in calves with
prior natural exposure to the organism (9). Further studies
with live P. haemolytica vaccines suggested a possible
protective role for capsular antigens (8). Others have indi-
cated that a neutralizing antibody to a P. haemolytica
cytotoxin (leukotoxin) may play a role in increased protec-
tion against pneumonia pasteurellosis (4, 14, 24).
Cytotoxin has been incriminated in the pathogenesis of
pneumonia pasteurellosis through its toxicity for ruminant
alveolar macrophages and peripheral blood leukocytes (2,
23). Antibody to cytotoxin has previously been measured
only by labor-intensive cytotoxin neutralization assays. The
purposes of this study were to develop an enzyme-linked
immunosorbent assay (ELISA) to detect serum antibody to
partially purified cytotoxin, to compare antibody responses
detected by ELISA to those detected by neutralization
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assays, and to determine the potential of the ELISA as a
predictor of resistance to experimental pneumonia pasteurel-
losis.
MATERIALS AND METHODS
Serum samples. Serum samples were obtained from 5- to
8-month-old calves which had been used in previous exper-
iments to evaluate the effects of various vaccines on resis-
tance to pneumonia pasteurellosis (9, 10, 22). On days 0 and
7, each calf was vaccinated subcutaneously with phosphate-
buffered saline (PBS), a bacterin consisting of 109 CFU of
Formalin-killed P. haemolytica in an aluminum hydroxide
adjuvant, or 5 x 109 CFU of live P. haemolytica (10, 11, 22).
Serum samples were collected on days 0, 7, 14, and 21 and
stored at -20°C. On day 21, calves were experimentally
challenged by transthoracic injection with 5 ml of a P.
haemolytica suspension in PBS containing approximately
109 CFU/ml (21). On day 25, calves were sacrificed, and lung
lesions were evaluated to determine the extent of lung
resistance to challenge exposure (22). Numerical scores
were awarded on the basis of morphologic criteria, which
included the size of the lesion and the degree of extension of
inflammation from the original lesion site. A maximum score
of 20 represented a severe lesion and lack of resistance,
whereas lower scores corresponded to increased resistance.
A total of 12 calves from each vaccination group were used
in the study.
Serologic evaluation. Antibodies to somatic antigens of P.
haemolytica were determined by a quantitative fluorometric
immunoassay (FIAX; International Diagnostic Technology,
Santa Clara, Calif.) with Formalin-killed 22-h cultures of P.
haemolytica serotype 1 as the antigens (6).
Serum cytotoxin neutralization titers were determined as
previously described (4, 14, 24). In general, these determi-
nations were made by preincubation of serial twofold dilu-
tions of test sera with crude cytotoxin, followed by
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significant difference (P < 0.05) was present between the
means of all three groups.
Correlation coefficients (r) and probabilities (P) for all
samples organized by parameter are given in Table 2.
Correlations of ELISA cytotoxin antibody responses with
cytotoxin neutralization titers, FIAX titers, and lesion
scores were all significant at P < 0.01. The strongest
correlation was between the ELISA cytotoxin antibody
response and cytotoxin neutralization titers, whereas the
lowest was between the ELISA cytotoxin antibody response
and FIAX titers, As an indicator of resistance to pneumonic
pasteurellosis, the ELISA correlated better with lesion
scores than did the FIAX. Cytotoxin neutralization titers
had the best correlation with lesion scores of all the param-
eters examined. Significant correlations were not obtained
between any parameters when samples were evaluated
within individual vaccine groups.
DISCUSSION
The result of this study was the development of a primary
binding immunoassay (ELISA) which is suitable for screen-
ing large numbers of bovine serum samples for antibody to
P. haemolytica cytotoxin. Previously reported ELISAs for
P. haemolytica have used sodium salicylate extracts (3, 12),
KSCN extracts (26), or saline extracts (7) of P. haemolytica
as antigens. The assay in the current report is the first direct


























FIG. 2. A490s of anticytotoxic bovine serum samples following
adsorption with four concentrations of various P. haemolytica
antigens. A, Nonadsorbed; B, Formalin-killed P. haemolytica; C,
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FIG. 3. Mean A490s and standard deviations of serum samples
from calves receiving live vaccine (A), bacterin (B), or PBS (con-
trols) (C).
haemolytica antigen. The ELISA results provide informa-
tion similar to that obtained by cytotoxin neutralization
while eliminating the need for serial dilutions of sera, prep-
aration of living cells, and use of radioisotopes.
Preadsorption studies with various P. haemolytica anti-
gens demonstrated the specificity of the ELISA reaction for
cytotoxin. When preincubated with high concentrations of
cytotoxin, antigen-binding sites on immunoglobulin which
were specific for cytotoxin apparently became saturated,
resulting in a marked decrease in the ELISA absorbance. In
contrast, high concentrations of Formalin-killed organisms
or saline extracts of P. haemolytica had only minimal effects
on the ELISA absorbance. These results suggest that
cytotoxin is not associated with structural components of the
bacteria and further supports its classification as a true
exotoxin (25).
Evaluation of the cytotoxin-neutralizing ability of sera
from feedlot cattle demonstrated significantly lower
cytotoxin-neutralizing activity in the sera of cattle that died
of fibrinous pneumonia than in the sera of cattle that died for
other reasons (24). Similar associations between pneumonia
and cytotoxin neutralization were found in studies of exper-
imentally induced disease (4, 14). A direct positive correla-
tion was demonstrated between resistance to experimental
challenge with P. haermolytica and serum cytotoxin neutral-
ization titers (14). As determined by a modified indirect
complement fixation test, however, antibodies to somatic
antigens of P. haemolytica appeared to be unrelated to the
development of pneumonia (4).
The results of this study support these findings and suggest
that exposure to live organisms or vaccines containing
cytotoxic antigens may be necessary to produce an
anticytotoxic immune response and that this response is a
better predictor of resistance to pneumonia than the immune
response to somatic antigens. ELISA cytotoxin antibody
responses and cytotoxin neutralization titers for the live-
vaccine group were both significantly higher than those for
the bacterin group. In association with this, mean lesion
scores for the live-vaccine group were significantly lower
J. CLIN. MICROfBIOL.
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TABLE 1. Antibody responses and lesion scores for cattle
challenged with P. haemolyticaa
Mean ± SD
ELISA
Group cytotoxin Cytotoxin Lesion
antibody neutralization FIAX titer' scored
response titerc
(A4so)b
PBS 0.39 ± 0.18 6.4 ± 5.1 28.5 ± 15.1 16.9 ± 4.5
Bacterin 0.30 ± 0.10 8.5 ± 5.2 102.7 ± 88.1 10.3 ± 5.4
Live vaccine 0.70 ± 0.22 88.0 + 36.4 173.2 ± 46.7 3.7 ± 2.5
a All antibody titers were detected on day 21 after the initial vaccination.
b Arithmetic mean.
C Geometric mean.
d Higher scores indicate a greater susceptibility to challenge.
(indicating greater resistance) than those for controls or the
bacterin group. The most significant correlation with lesion
scores was obtained with cytotoxin neutralization titers,
suggesting this to be the test of choice in experimental trials
with small sample sizes. For rapid analysis of large numbers
of serum samples, however, the ELISA is an excellent
alternative.
Thé relationship between the antigens of P. haemolytica
and resistance to disease is becoming more clearly defined.
Bacterins stimulate a somatic antibody response which does
not consistently provide protection from disease and in some
cases has been incriminated in enhancing disease (13, 27). In
the current study, there was a significant reduction in the
lesion scores of bacterin-vaccinated animals as compared
with controls, however, indicating that some degree of
protection may have been afforded by antibodies to somatic
antigens. Alternatively, this reduction may have been
caused by the presence of low levels of anticytotoxin anti-
bodies or antibodies to somatic antigens which cross-react
with cytotoxic antigens. Animals which received live vac-
cine and possessed high levels of cytotoxin antibodies deter-
mined by the ELISA and neutralization assays had lesion
scores which were significantly lower (indicating greater
resistance) than those for the bacterin group. Although
additional protection was associated with increased levels of
anticytotoxin antibodies, animals with good neutralization
titers or ELISA cytotoxin antibody responses occasionally
still developed severe pneumonic lesions. The reasons or
factors involved in these cases are unknown.
The pathogenesis of pneumonic pasteurellosis is complex.
A successful product for immunologic prevention of the
disease will most likely have to take into account multiple
antigenic features of Pasteurella spp. The ELISA described
TABLE 2. Regression analysis of antibody responses and
lesion scores
Cytotoxin
neutralization FIAX titer Lesion score
Parameter titer
r P r P r P
ELISA (A490) 0.675 0.0001 0.425 0.0097 -0.509 0.0015
Cytotoxin 0.662 0.0001 -0.605 0.0001
neutralization
titer
FIAX titer -0.473 0.0036
a Pearson product-moment.
in this report provides a helpful tool for more clearly defining
the role played by cytotoxin in pneumonic pasteurellosis.
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